IVEVF
Inventiva S.A.
$5.33
0.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 22, 2026
SEC
Inventiva filed its notice of meeting for the Ordinary and Extraordinary General Meeting scheduled June 30, 2026. Key it
6-K — Impact 6/10
Apr 8, 2026
SEC
Inventiva S.A. reported a significant decline in revenue to $4.5 million in 2025 from $9.2 million in 2024, driven by lo
20-F — Impact 6/10
Mar 30, 2026
SEC
Inventiva reported 2025 full-year results with revenues declining to $4.5 million from $9.2 million in 2024, driven by l
6-K — Impact 6/10
Analyst Ratings
8Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Latest Reports
BEARISH
6-K
6/10
Inventiva filed its notice of meeting for the Ordinary and Extraordinary General Meeting scheduled June 30, 2026. Key it
May 22, 2026
BEARISH
20-F
6/10
Inventiva S.A. reported a significant decline in revenue to $4.5 million in 2025 from $9.2 million in 2024, driven by lo
Apr 8, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 1 mixed, 0 neutral. Avg impact: 6.0/10.
BEARISH
6-K
6/10
Inventiva filed its notice of meeting for the Ordinary and Extraordinary General Meeting scheduled J
May 22, 2026
BEARISH
20-F
6/10
Inventiva S.A. reported a significant decline in revenue to $4.5 million in 2025 from $9.2 million i
Apr 8, 2026
MIXED
6-K
6/10
Inventiva reported 2025 full-year results with revenues declining to $4.5 million from $9.2 million
Mar 30, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 94% buy across 16 analysts — 8 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 20.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 2082.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 8 | 7 | 1 | 0 | 0 | 94% | |
| Apr 1, 2026 | 8 | 7 | 1 | 0 | 0 | 94% | |
| Mar 1, 2026 | 7 | 7 | 1 | 0 | 0 | 93% | |
| Feb 1, 2026 | 7 | 7 | 1 | 0 | 0 | 93% | |
| Jan 1, 2026 | 6 | 7 | 1 | 0 | 0 | 93% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.